NDRA ENDRA Life Sciences Inc.

NASDAQ
$4.49

ENDRA Life Sciences Inc. (NDRA) Institutional Ownership

What the institutions did with NDRA last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
11
filed a 13F this quarter
Managers holding
10
+2 on the quarter
Buyers
5
3 opened new
Sellers
3
1 sold out entirely
Buyer share
62.5%
of managers who traded it
Breadth
+25.0
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
Altium Capital Management LLC 59.3K 38.6%
CITADEL ADVISORS LLC 29.9K 19.5%
CITIZENS FINANCIAL GROUP INC/RI 28.4K 18.5%
GEODE CAPITAL MANAGEMENT, LLC 14.9K 9.7%
VANGUARD FIDUCIARY TRUST CO 10.1K 6.6%
VANGUARD CAPITAL MANAGEMENT LLC 7.3K 4.8%
MORGAN STANLEY 3.5K 2.3%
UBS Group AG 68 0.0%
Tower Research Capital LLC (TRC) 58 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 19 0.0%

Largest changes

Manager Action Previous Current Change
CITADEL ADVISORS LLC New 0 29.9K +29.9K
CITIZENS FINANCIAL GROUP INC/RI New 0 28.4K +28.4K
Altium Capital Management LLC Increased 51.9K 59.3K +7.4K
GEODE CAPITAL MANAGEMENT, LLC Reduced 21.1K 14.9K -6.2K
VANGUARD CAPITAL MANAGEMENT LLC Increased 2.8K 7.3K +4.5K
UBS Group AG Reduced 152 68 -84
Tower Research Capital LLC (TRC) New 0 58 +58
Caitong International Asset Management Co., Ltd Sold Out 4 0 -4

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.